ZHENGE BIOTECH
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
ZHENGE BIOTECH
Industry:
Biotechnology Manufacturing Pharmaceutical
Founded:
2017-11-07
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.zgbiotech.com
Total Employee:
501+
Status:
Active
Total Funding:
235.74 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Mobile Non Scaleable Content Pound Sterling Japanese Yen Baidu Analytics
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Arranta Bio
Arranta Bio is a superior Contract Development Manufacturing Organization.
Chime Biologics
Chime Biologics is a biopharmaceutical development and manufacturing company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Encube Ethicals
Encube Ethicals a contract development and manufacturing organization, specializes in topical semisolid formulations.
Intas Pharmaceuticals
Intas Pharmaceuticals is a global pharmaceutical formulation development, manufacturing and marketing company.
RoslinCT
RoslinCT is a UK Cell Therapy Contract Development and Manufacturing Organisation.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
Sinovac Biotech
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization
Stargazer Pharmaceuticals
Stargazer Pharmaceuticals offers the therapy of standards disorder and manufacturer of pharmaceuticals products.
Current Advisors List
Current Employees Featured
Founder
Investors List
Shanghai Pudong Science and Technology Investment
Shanghai Pudong Science and Technology Investment investment in Series C - Zhenge Biotech
High Hope Group
High Hope Group investment in Series C - Zhenge Biotech
Sinopharm-CICC
Sinopharm-CICC investment in Series C - Zhenge Biotech
LYFE Capital
LYFE Capital investment in Series C - Zhenge Biotech
Junxin Yingtai Investment
Junxin Yingtai Investment investment in Series C - Zhenge Biotech
Novo Holdings
Novo Holdings investment in Series C - Zhenge Biotech
Sofina
Sofina investment in Series C - Zhenge Biotech
Goldman Sachs Asset Management
Goldman Sachs Asset Management investment in Series C - Zhenge Biotech
IDG Capital
IDG Capital investment in Series C - Zhenge Biotech
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Zhenge Biotech
Official Site Inspections
http://www.zgbiotech.com Semrush global rank: 12.19 M Semrush visits lastest month: 126
- Host name: 101.132.41.152
- IP address: 101.132.41.152
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Zhenge Biotech"
ZG Biotech Company Profile | Management and Employees List
[email protected]: 5: first: [email protected]: 6: last: [email protected]: Your Questions, Our Answers Get Free Access to ZG Biotech Contacts Info. What is ZG Biotech …See details»
ZhenGe Biotech - Craft
Jan 11, 2022 ZhenGe Biotech (also known as Shanghai ZhenGe Biotech, Zgbiotech) is a contract development and manufacturing organization (CDMO) for macromolecular …See details»
关于臻格-臻格生物 - 上海臻格生物技术有限公司
臻格生物自2017年成立以来，即以行业领先的大规模动物细胞培养技术闻名于大分子医药领域。团队成员曾开发用于抗体生产的流加培养工艺，表达量达到15 g/L，为当时业界纪录。See details»
Zhenge Biotech - Crunchbase Company Profile & Funding
Zhenge Biotech offers integrated contract development and manufacturing organization services, covering from pre-clinical research to commercial production. Molecular Drug Development …See details»
ZhenGe Biotech - Owler
ZhenGe Biotech’s Profile, Revenue and Employees. ZhenGe Biotech is a China-based contract development organization that provides services such as clinical research and cell line …See details»
管理团队-臻格生物 - 上海臻格生物技术有限公司
臻格生物的专业团队在大分子药物研发、分析、生产、质量、供应链以及国内外注册等方面拥有丰富经验。自公司成立以来，员工总数年均倍增，目前已超过600人。See details»
ZG Biotech - Overview, News & Similar companies - ZoomInfo
ZG Biotech contact info: Phone number: +86 2168189888 Website: www.zgbiotech.com What does ZG Biotech do? Since its establishment in 2017, Zhenge Biology has been known in the …See details»
上海臻格生物技术有限公司：官网、创业项目及相关资讯 - VCNEWS
上海臻格生物技术有限公司(以下简称“臻格生物”)成立于2017年11月7日，注册资本5000万元人民币，注册地为上海市临港奉贤园区，研发中心位于上海张江高科技园区，核心业务为大分子生物 …See details»
上海臻格生物技术有限公司 - 爱企查
简介： 1、基本情况 上海臻格生物技术有限公司是一家瞪羚企业(2024)、独角兽企业，该公司成立于2017年11月07日，位于中国（上海）自由贸易试验区临港新片区正嘉路289号，目前处于开 …See details»
ZGBiotech - Company Profile - Tracxn
Feb 9, 2025 ZGBiotech - CDMO focused on drug development, analytical, formulation, and quality testing services. Raised a total funding of $240M over 4 rounds from 16 investors. …See details»
Shanghai Zhenge Biotechnology Co., Ltd. - synapse.zhihuiya.com
The COVID-19 outbreak has become a global pandemic responsible for over 2,000,000 confirmed cases and over 126,000 deaths worldwide. In this study, we examined the immunogenicity of …See details»
上海臻格生物技术有限公司行业信息 - 企查查
Dec 15, 2024 企查查为您提供上海臻格生物技术有限公司最新的行业信息查询，包括行业资质，行业资格等详细信息，让您在选择上海臻格生物技术有限公司前能够做到全面了解公司的工 …See details»
Biosion and ZhenGe Biotech Sign Global Strategic
Apr 10, 2020 Biosion Inc. and Shanghai ZhenGe Biotechnology Co. Ltd. jointly announced today that the two parties have signed a global strategic partnership agreement, to launch multiple …See details»
上海臻格生物技术有限公司 - 盖德化工网
Nov 7, 2017 公司简介 上海臻格生物技术有限公司是一家主要从事技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广的公司。 公司成立于2017年11月7日，注册资本为18000 …See details»
公司进展｜臻格生物研发生产项目二期开工仪式隆重举行
中国上海，2022年3月9日上午10点18分，上海臻格生物技术有限公司（以下简称“臻格生物”）在上海临港新片区“生命蓝湾”举行臻格生物研发生产项目二期开工建设仪式，标志着臻格生物在新 …See details»
Funding Update | Zencore Biologics Raises USD 100 million Round …
Zencore Biologics provides one-stop Contract Development and Manufacturing Organization (CDMO) services and offers end-to-end solutions to help customers discover, develop, and …See details»
新品首发！免费试用 | Zncore® CHO平台系列培养基-臻格生物
Mar 18, 2023 臻格生物作为专业的全方位cdmo服务商和全产业周期培养基解决方案提供商，持续助推国内外药企大分子生物药研发及商业化进程，致力于集工艺之大成，做人人都能用得起的 …See details»
Federal government announces support for cutting-edge, AI- and …
1 day ago OmniaBio Inc. is a technology-focused, global cell and gene therapy contract development and manufacturing organization. A subsidiary of the Centre for …See details»
热烈祝贺博奥信抗Siglec-15创新单克隆抗体候选药物在美国获批临 …
2022年12月2日-博奥信合作伙伴Pyxis Oncology(NASDAQ:PYXS)宣布抗Siglec-15单抗PYX-106(BSI-060T)获得美国食品药品监督管理局(FDA)临床试验批准，臻格生物表示热烈祝贺！See details»
细胞株开发-臻格生物 - 上海臻格生物技术有限公司
在生物制药领域，传统的细胞株构建方法需要5-6个月，完成生产用单克隆细胞株的开发，臻格生物仅需3个月即可完成自蛋白序列到单克隆细胞株的构建。See details»